HERLEV, Denmark , May 8, 2025 /PRNewswire/ -- Nordic Bioscience announces that its PRO-C3 test is launched by Roche Diagnostics on their cobas analysers. The Roche Elecsys® PRO-C3, used with ...

"The Elecsys PRO-C3 test is the first test launched from the collaboration between Nordic Bioscience and Roche Diagnostics. We are proud that our technology becomes globally available to make a ...

Nordic Bioscience introduces nordicEndotrophin™, a fully automated high-precision assay that selectively quantifies the ...

Roche is rolling out a new diagnostic test to ... The company said its 18-minute Elecsys PRO-C3 blood test, run on its cobas e instruments, is used alongside a formula that accounts for other ...

The Swiss pharma has inked several collaborations in this field, suggesting it sees the approach as promising to rid the body ...

Roche's Itovebi was the first PI3K inhibitor to get approved as a first-line treatment for breast cancer last year – and new survival data to be presented at the upcoming ASCO congress looks set ...